The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 701–800 of 999
Kashyap, S. R., Belfort, R., Cersósimo, E., Lee, S., & Cusi, K. J. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00013.x · Cited by 21
Kahri, J., Soro‐Paavonen, A., Ehnholm, C., & Taskinen, M. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/12587 · Cited by 21
Exercise and Coronary Heart Disease Risk Markers in South Asian and European Men
Arjunan, S. P., BISHOP, N. C., Reischak-Oliveira, Á., & Stensel, D. J. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182853ecf · Cited by 21
“Paragraph number 27 Interleukin-6 and sICAM-1 were assessed in the present study because both are indicative of chronic low grade inflammation which in turn is associated with an increased risk of type 2 diabetes and CHD (11, 14, 21).”
BackgroundProtective effects of red wine polyphenolic compounds on the cardiovascular system.
Zenebe, W. J., Pecháňová, O., & Bernátová, I. (2001) · PubMed Central · Cited by 21
Psychoneuroimmunology of Depressive Disorder: Mechanisms and Clinical Implications
Capuron, L., Miller, A. H., & Irwin, M. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50030-7 · Cited by 22
van der Harst, P., Voors, A. A., Volbeda, M., Buikema, H., van Veldhuisen, D. J., & van Gilst, W. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.030 · Cited by 21
Albert, M. A., Glynn, R. J., Buring, J. E., & Ridker, P. M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.051 · Cited by 21
Novel serologic markers of cardiovascular risk
Oliveira, G. H. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0038-9 · Cited by 21
“In the Physicians’ Health Study, elevated initial serum levels of ICAM-1 were found to be an independent risk factor for future MI [ 44 ].”
BackgroundEndothelial dysfunction in HIV infection
Cotter, B. R. (2006) · Current HIV/AIDS Reports · doi:10.1007/bf02696656 · Cited by 21
“HIV and endothelial adhesion molecules Elevated levels of soluble cellular adhesion molecules represent early markers of the development of atherosclerosis [ 34 ].”
BackgroundStatins and inflammatory markers
Case, C. C., & Ballantyne, C. M. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0061-z · Cited by 21
“Statins and Inflammatory Markers • Case and Ballantyne 43 lowed prospectively [ 9 ].”
BackgroundRelationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation
Labarrere, C. A. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199903000-00010 · Cited by 21
Mendivil, C. O., Robles‐Osorio, L., Horton, E. S., Hamdy, O., & Caballero, A. E. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-37 · Cited by 20
“In prospective studies, sICAM-1 has been positively associated with the risk of myocardial infarction among initially healthy individuals [21,22].”
Backgroundvan der Harst, P., Asselbergs, F. W., Hillege, H. L., Bakker, S. J. L., Voors, A. A., van Veldhuisen, D. J., & van Gilst, W. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.054 · Cited by 20
Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients
Papanas, N., Tziakas, D. N., Chalikias, G. K., Floros, D., Trypsianis, G. A., Papadopoulou, E., Kortsaris, A., Symeonidis, G., Souliou, E., Maltezos, E. S., et al. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70289-6 · Cited by 20
Sjögren, P., Cederholm, T., Heimbürger, M., Stenvinkel, P., Vedin, I., Palmblad, J. E. W., & Hellénius, M.-L. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.182 · Cited by 20
“activity that in turn has been associated with an unfavourable cardiovascular prognosis (Ridker et al., 1998; Tzoulaki et al., 2005; Deanfield et al., 2007).”
BackgroundHakonarson, H. H. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0011-0 · Cited by 20
“Leukocyte adherence to the vascular endothelium is one of the earliest detectable cellular changes in atherosclerosis [ 30 ].”
BackgroundLiang, K., Lee, W., Lee, W.-L., Chen, Y., Ting, C.-T., & Sheu, W. H. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.003 · Cited by 20
Chiu, Y.-H. M., Garshick, E., Hart, J. E., Spiegelman, D. L., Dockery, D. W., Smith, T. J., & Laden, F. (2016) · Environmental Research · doi:10.1016/j.envres.2016.04.008 · Cited by 20
“2007), and studies suggest that a greater level of peripheral blood sICAM-1 is associated with the development of symptomatic peripheral arterial disease and MI in healthy individuals (Blake and Ridker 2002; Ridker et al. 1998).”
BackgroundHaas, M. J., Jurado-Flores, M., Hammoud, R., Feng, V., Gonzales, K., Onstead‐Haas, L., & Mooradian, A. D. (2017) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000648 · Cited by 21
Mortensen, L. A., Bistrup, C., Stubbe, J., Carlström, M., Checa, A., Wheelock, C. E., Palarasah, Y., Bladbjerg, E., Thiesson, H. C., & Jensen, B. L. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00025.2019 · Cited by 20
Effects of huoxin formula on the arterial functions of patients with coronary heart disease
Xu, Y., Hu, H., Li, Y., Cen, R., Yao, C., Ma, W., Huang, M., Yin, Y., Gao, H., Liu, Y., et al. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1561726 · Cited by 20
“ICAM-1 has been reported to be involved in early AS formation and angina (Hwang et al. 1997; Ridker 1998; Jude et al. 2002; Luc et al. 2003; Fotis et al. 2012) and anti-adhesion therapies have been proposed as a novel means to prevent cardiovascular disease progression (Ridker et al. 1998).”
BackgroundAhn, N., & Kim, K. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165910 · Cited by 22
“Moreover, progression to chronic inflammation and CVD, including atherosclerosis, triggered by endothelial cell activation [18], is characterized by accompanying complications [19,20].”
BackgroundLiang, K., Sheu, W. H., Lee, W.-L., Liu, T.-J., Ting, C.-T., Chen, Y., & Lee, W. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70938-2 · Cited by 20
“In terms of adhesion molecules, several large studies (28-30) have shown that baseline ICAM-1 is a marker for predicting future cardiovascular events in healthy people and that VCAM-1 is a predictor for the prognosis of CAD patients.”
ResultPola, R., Flex, A., Gaetani, E., Papaleo, P., Martini, D. D., Gerardino, L., Serricchio, M., Pola, P., & Bernabei, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00337-3 · Cited by 20
Scott, D. A., Todd, D. H., Coward, P. Y., Wilson, R. F., Odell, E. W., Poston, R. N., Matthews, J. P., & Palmer, R. M. J. (2000) · Addiction Biology · doi:10.1080/13556210050003793 · Cited by 20
Vascular aetiology of erectile dysfunction
Francavilla, S., Bocchio, M., Pelliccione, F., Necozione, S., & Francavilla, F. (2005) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00584.x · Cited by 20
Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia
Benítez, M. B., Cuniberti, L. A., Fornari, M. C., Rosso, L. A. G., Berardi, V. E., Elikir, G. D., Stutzbach, P. G., Schreier, L. E., Wikinski, R. L. W., & Brites, F. D. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.005 · Cited by 20
“[7] Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J.”
Pulawski, E., Mellwig, K., Brinkmann, T., Kleesiek, K., & Horstkotte, D. (2002) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2002.00405.x · Cited by 20
Couillard, C., Pomerleau, S., Ruel, G., Archer, W. R., Bergeron, J., Couture, P., Lamarche, B., & Bergeron, N. (2006) · Nutrition · doi:10.1016/j.nut.2006.03.007 · Cited by 21
Hove, C. E. V., Carreer-Bruhwyler, F., Géczy, J., & Herman, A. G. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.018 · Cited by 20
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy
Sekhar, R. V., Jahoor, F., Pownall, H. J., Ballantyne, C. M., & Balasubramanyam, A. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0029-2 · Cited by 20
“Increased plasma concentrations of intercellular adhesion molecule and P-selectin have been described as independent predictors of myocardial infarction in healthy individuals [ 56 ].”
BackgroundCardioprotection With High-Density Lipoproteins
Das, D. K. (2003) · Circulation Research · doi:10.1161/01.res.0000058881.44913.7b · Cited by 21
for the Prospective Study of Pravastatin in the Elderly at Risk Trial Study Group, Sattar, N., Murray, H. M., Welsh, P., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1217-3 · Cited by 19
“These data extend existing data in middle-aged individuals, since, in general, reported associations of circulating ICAM-1 with diabetes risk [3, 4] appear to be of greater magnitude than their associations with CVD risk [5].”
ResultNovos fatores de risco cardiovascular
Henrique, G., de Oliveira, M., & Farmer, J. A. (2003) · Rev. SOCERJ · Cited by 20
Impact of high serum Immunoglobulin E levels on the risk of atherosclerosis in humans
Ünal, D., Gelincik, A. A., Elitok, A., Demir, S., Olgaç, M., Coşkun, R., Kocaağa, M., Çolakoğlu, B., & Büyüköztürk, S. (2017) · Asia Pacific Allergy · doi:10.5415/apallergy.2017.7.2.74 · Cited by 17
“[33] indicated that the plasma concentration of soluble ICAM1 is elevated many years before the first myocardial infarction.”
BackgroundAnti-Inflammatory Drugs in Patients with Ischemic Heart Disease
Lázaro, A. M. P., Blanco‐Colio, L. M., Peláez, J. A. F., & Tuñón, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132835 · Cited by 19
“Several studies of patients with ACS have demonstrated not only increased plasma levels of inflammatory molecules (MCP-1, adhesion molecules, MMPs, or CD40 ligand (CD40L)), but also enhanced NF-κB activity in circulating leukocytes [28,29].”
BackgroundPeres, B. U., Allen, A. J. H., Daniele, P., Humphries, K. H., Taylor, C. M., Laher, I., Almeida, F. R., Jen, R., Sandford, A. J., van Eeden, S. F., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255306 · Cited by 19
Monocyte adhesion in diabetic angiopathy
Renier, G., Mamputu, J., Desfaits, A.-C., & Serri, O. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00271-4 · Cited by 19
McGlinchey, P. G., Spence, M. S., Patterson, C. C., Allen, A. R., Murphy, G., Belton, C., & McKeown, P. (2004) · European Journal of Immunogenetics · doi:10.1111/j.1365-2370.2004.00474.x · Cited by 19
ICAM-1 Polymorphisms (G241R, K469E), in Coronary Artery Disease and Myocardial Infarction
Aminian, B., Ardekani, A. R. A., & Arandi, N. (2007) · PubMed · doi:10.22034/iji.2007.17202 · Cited by 19
Sarecka‐Hujar, B., Żak, I., & Krauze, J. (2008) · PubMed · Cited by 19
Temu, T. M., Polyak, S. J., Zifodya, J. S., Wanjalla, C. N., Koethe, J. R., Masyuko, S. J., Nyabiage, J., Kinuthia, J., Gervassi, A. L., Oyugi, J. O., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa425 · Cited by 19
“Elevated levels of endothelial activation molecules including soluble/circulating intercellular (sICAM-1) and vascular (sVCAM-1) adhesion molecule–1 have been shown to predict future CVD events in the general population and those with CVD [10, 11].”
BackgroundPresent and Future Biochemical Markers for Detection of Acute Coronary Syndrome
Eriksson, S., Wittfooth, S., & Pettersson, K. S. I. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360600793082 · Cited by 19
Ottaviani, C., Shapiro, D., Goldstein, I. B., & Mills, P. J. (2007) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2007.05.013 · Cited by 20
“Prospective data (Hwang et al., 1997; Ridker et al., 1998) demonstrate an 80% higher risk of future myocardial infarction for subjects in the highest quartile at study entry (sICAM-1>260 ng/mL), independently of the traditional cardiovascular risk factors mentioned above.”
BackgroundGrooteman, M. P. C., Gritters, M., Wauters, I., Schalkwijk, C. G., Stam, F., Twisk, J. W. R., ter Wee, P. M., & Nubé, M. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi126 · Cited by 19
“As mentioned, both sCAM and vWf have been correlated with CVD and mortality in renal and non-renal patients [8,9].”
BackgroundAssociation of factor VII levels with inflammatory parameters in hypercholesterolemic patients
Porreca, E., Febbo, C. D., Castelnuovo, A. F. D., Baccante, G., Amore, C., Angelini, A., Nisio, M. D., Donati, M. B., Cuccurullo, F., & Iacoviello, L. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00199-5 · Cited by 19
Biochemical markers surrogating on vascular effects of sex steroid hormones
Mueck, A. O., & Seeger, H. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600629258 · Cited by 19
“Recent investigations showed that a soluble form of adhesion molecules can be measured in the serum [16].”
BackgroundLipoprotein (a), Lipids, Aspirin, and Risk of Myocardial Infarction in the Physician's Health Study
Ariyo, A., Hennekens, C. H., Stampfer, M. J., & Ridker, P. M. (1998) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679800500410 · Cited by 19
Blum, A., & Cannon, R. O. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04016.x · Cited by 19
Effects of shear stress and flow pulsatility on endothelial function
Vita, J. A., & Mitchell, G. F. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.020 · Cited by 19
“Serum markers of endothelial activation may provide similar prognostic information (2,3).”
BackgroundIncrease of orexin A in the peripheral blood of adolescents with Internet gaming disorder
Choi, M., Cho, H., Chun, J., Yoo, J. H., & Kim, D. (2020) · Journal of Behavioral Addictions · doi:10.1556/2006.8.2019.65 · Cited by 17
“First, sICAM-1 is elevated in atherosclerosis, myocardial infarction, and cardiovascular diseases, indicating its potential as a biomarker for vascular inflammation (Hwang et al., 1997; Noutsias et al., 2003; Ridker et al., 1998).”
BackgroundCirculating adhesion molecules after short-term exposure to particulate matter among welders
Fang, S. C., Eisen, E. A., Cavallari, J. M., Mittleman, M. A., & Christiani, D. C. (2009) · Occupational and Environmental Medicine · doi:10.1136/oem.2008.043794 · Cited by 18
Rodríguez‐Carrio, J., Alpéri, M., López‐Mejías, R., López, P., Ballina‐García, F. J., Abal, F., González-Gay, M. Á., & Suárez, A. (2016) · Clinical Science · doi:10.1042/cs20160374 · Cited by 18
Temu, T. M., Zifodya, J. S., Polyak, S. J., Wagoner, J., Wanjalla, C. N., Masyuko, S. J., Nyabiage, J., Kinuthia, J., Bloomfield, G. S., Page, S. T., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002729 · Cited by 18
“This is important as sICAM-1 and sVCAM-1 have been found to predict risk of future CVD events [9,10].”
BackgroundPathophysiology of Atherosclerosis
Prasad, K. (2000) · Springer eBooks · doi:10.1007/978-1-4612-1190-7_6 · Cited by 18
The acute phase response and atherosclerosis
Lowenstein, C. J., & Matsushita, K. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.08.001 · Cited by 18
[Role of inflammation in atherogenesis].
Rodríguez, G., Mago, N., & Rosa, F. (2009) · PubMed · Cited by 26
Faktor yang Memengaruhi Kualitas Hidup Pasien dengan Penyakit Jantung Koroner
Nuraeni, A. (2016) · Jurnal Keperawatan Padjadjaran · doi:10.24198/jkp.v4n2.1 · Cited by 18
Folic acid, inflammation, and atherosclerosis: False hopes or the need for better trials?
Mangoni, A. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.11.016 · Cited by 17
Leitner, J. M., Pernerstorfer-Schön, H., Weiss, A., Schindler, K., Rieger, A., & Jilma, B. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.001 · Cited by 17
Zhang, W.-J., Stocker, R., McCall, M. R., Forte, T. M., & Frei, B. B. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00247-2 · Cited by 18
“adhesion molecules are associated with coronary events [10,11]; and a deficiency of adhesion molecules in knockout mice lacking the genes for VCAM-1, ICAM-1 and/ or P-selectin significantly reduces the formation of atherosclerotic fatty streaks [9,43,44].”
BackgroundMarkers of cardiac ischemia, injury, and inflammation
Newby, L. K. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2003.12.006 · Cited by 18
Pizza and Vegetables Don’t Stick to the Endothelium
Giugliano, D., Nappo, F., & Coppola, L. (2001) · Circulation · doi:10.1161/01.cir.104.7.e34 · Cited by 18
Best, P. J. M. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2661 · Cited by 18
“In a nested case-control study from the Physicians’ Health Study in healthy men, soluble ICAM-1 predicted future myocardial infarctions([1]).”
BackgroundLaboratory surrogates for anti-atherosclerotic drug development
Stein, E. A. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01421-7 · Cited by 18
Inflammation in acute coronary syndromes.
Robbins, M. A., & Topol, E. J. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_2.sii130 · Cited by 18
Quality of sleep in people living with HIV in the era of highly active antiretroviral treatment
Petrakis, V., Steiropoulos, P., Παπάνας, Ν., Trypsianis, G. A., Papazoglou, D., & Panagopoulos, P. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624221146608 · Cited by 17
“Chronic sleep disturbances, common in an aging population, could have an inflammatory component leading to cardiovascular morbidity and mortality.(6,7) Sleep disturbances in people living with human immunodeficiency virus (PLWHIV) have been documented since the early stage of the HIV epidemic.”
BackgroundTutoğlu, A., Boyacı, A., Boyacı, N., Kaya, Z., Aridici, R., & Koca, İ. (2014) · Journal of Physical Therapy Science · doi:10.1589/jpts.26.1093 · Cited by 17
Lind, L., Johansson, A., Hedner, E., & Hulthe, J. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s19161 · Cited by 17
Gazı, E., Barutçu, A., Altun, B., Temız, A., Bekler, A., Urfalı, M., Sılan, F., Çölkesen, Y., & Özdemir, Ö. (2014) · Medical Principles and Practice · doi:10.1159/000363451 · Cited by 15
Datta, S., Iqbal, Z., & Prasad, R. K. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0100-4 · Cited by 17
“interleukin (IL-6) [20, 21], serum amyloid A (SAA) [ 22 ], Tumour necrosis factor-a (TNF-a )[ 23], CD40 ligand [24].”
Karásek, D., Vaverková, H., Halenka, M., Budı́ková, M., & Novotný, D. (2005) · Biomedical Papers · doi:10.5507/bp.2005.012 · Cited by 17
Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease
Batuca, J. R., Amaral, M., Favas, C., Justino, G. C., Papoila, A. L., Ames, P. R. J., & Alves, J. D. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645857 · Cited by 16
Álvarez, B., Yugueros, X., Fernández, E., Luccini, F., Gené, A., & Matas, M. (2012) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2011.05.047 · Cited by 17
Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes
Heliövaara, M. K., Herz, M., Teppo, A.-M., Leinonen, E. S., & Ebeling, P. R. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346296 · Cited by 17
Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020038 · Cited by 17
“Besides, it was shown that soluble ICAM-1 is correlated with the severity of atherosclerosis, that its inhibition can retard atherogenesis [106-108] and that ICAM-1 can serve as a predictor of vascular events [109].”
BackgroundFortes, P. C. N., Versari, P. H., Stinghen, A. E. M., & Pecoits‐Filho, R. (2007) · Peritoneal Dialysis International · doi:10.1177/089686080702702s14 · Cited by 17
“Also notable are the strong associations between surrogate markers of inflammation and plasma levels of adhesion molecules (11).”
BackgroundKemény, Á., Csekő, K., Szitter, I., Varga, Z. V., Bencsik, P., Kiss, K., Halmosi, R., Deres, L., Erős, K., Perkecz, A., et al. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.04.098 · Cited by 17
“: increased risk of myocardial infarction (Ridker et al., 1998), in addition chronic smokers have elevated levels of sICAM-1 (Rohde et al.”
BackgroundGarcía‐Vicente, S., Abella, A., Viguerie, N., Ros-Baró, A., Camps, M., Testar, X., Palacı́n, M., Zorzano, A., & Marti, L. (2005) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167057 · Cited by 17
Increased Endothelial Injury in Septic Patients With Coronary Artery Disease
Kern, H., Wittich, R., Rohr, U., Kox, W. J., & Spies, C. (2001) · CHEST Journal · doi:10.1378/chest.119.3.874 · Cited by 17
Atherosclerosis and plaque rupture
Welt, F. G. P., & Simon, D. I. (2001) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.1130 · Cited by 17
“Human studies have demonstrated that plasma levels of intercellular adhesion molecule-1 (ICAM-1) and E-selectin correlate with clinical manifestations of coronary atherosclerosis [5].”
BackgroundTonstad, S., Thorsrud, H., Torjesen, P. A., & Seljeflot, I. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.006 · Cited by 17
Dugué, B., Leppänen, E., & Gräsbeck, R. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1543 · Cited by 17
“Soluble adhesion proteins such as sICAM-1 may become important markers for early atherosclerosis ( 1 ) and some other diseases [e.g., see Refs.”
BackgroundVascular Function and Mild Renal Impairment in Stable Coronary Artery Disease
van der Harst, P., Smilde, T. D. J., Buikema, H., Voors, A. A., Navis, G. J., van Veldhuisen, D. J., & van Gilst, W. H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000197844.06411.22 · Cited by 17
Coronary risk factors: new perspectives
Niccoli, G., Iacoviello, L., Cianflone, D., & Crea, F. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.suppl_1.s41 · Cited by 17
Cytomegalovirus Infection and Coronary Heart Disease
Nieto, F. J., Szklo, M., & Sorlie, P. D. (1999) · Circulation · doi:10.1161/01.cir.100.25.e139 · Cited by 17
Imani, M. M., Sadeghi, M., Gholamipour, M. A., Brühl, A. B., Bahmani, D. S., & Brand, S. (2022) · Medicina · doi:10.3390/medicina58101499 · Cited by 16
“Given this, ICAM-1 level can be considered a reliable predictor of CAD, similar to C-reactive protein (CRP) [66].”
Resultvon Känel, R., Hong, S. J., Pung, M. A., & MILLS, P. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.01.005 · Cited by 16
“The risk of first-time myocardial infarction was previously increased with increasing quartiles of IL-6 and sICAM-1 concentrations.(12,13) In our group of individuals, secondto-third and third-to-fourth quartile transitions in sICAM-1 levels corresponded with MAP increases of 15 and 18 mm Hg, respectively.”
BackgroundA role for innate immunity in the development of hypertension
Gomolak, J. R., & Didion, S. P. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2013.12.027 · Cited by 16
Bogavac‐Stanojević, N., Djurovic, S., Jelić‐Ivanović, Z., Spasojević‐Kalimanovska, V., & Kalimanovska‐Oštrić, D. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.135 · Cited by 16
“Other authors reported that elevated ICAM-1 concentration was associated with the increased risk for acute coronary events (18, 31) or adverse events in patients with peripheral arterial disease (32).”
BackgroundAlissa, E. M., Bahjri, S. M., Alama, N., Ahmed, W. H., & Ferns, G. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.09.007 · Cited by 16
Murphy, N., Grimsditch, D. C., Vidgeon-Hart, M., Groot, P. H. E., Overend, P., Benson, G. M., & Graham, A. (2005) · Disease Markers · doi:10.1155/2005/394152 · Cited by 16
“Significantly, emerging data suggest that elevated levels of sICAM-1 may be predictive of future risk of coronary artery disease [6,13], while sVCAM-1 levels are strongly prognostic of the extent and severity of existing atherosclerosis [9–11], reviewed in [13].”
BackgroundAssociation between ABO Genotype and Risk of Hepatocellular Carcinoma in Koreans
Shim, H.-J., Lee, R., Shin, M., Kim, H. N., Cho, D., Ahn, H.-R., & Kweon, S. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.7.2771 · Cited by 16
“…an SNP at the ABO locus was found to be statistically significantly associated with plasma levels of soluble intercellular adhesion molecule 1, which is a marker of inflammation associated with the risk of incident diabetes (Meigs et al., 2004) and myocardial infarction (Ridker et al., 1998).”
BackgroundLuchting, B., Hinske, L. C., Rachinger-Adam, B., Celi, L. A., Kreth, S., & Azad, S. C. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0246 · Cited by 16
Doo, Y., Han, S.-J., Han, S.-W., Park, W.-J., Choi, S., Cho, G., Hong, K.-S., Han, K., Lee, N., Oh, D., et al. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280206 · Cited by 16
van Haelst, P. L., Tervaert, J. W. C., van Geel, P. P., Veeger, N. J. G. M., Gurné, O., Gans, R. O. B., & van Gilst, W. H. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(03)00084-4 · Cited by 16
Apeland, T., Mansoor, M. A., Seljeflot, I., Brønstad, I., Gøransson, L. G., & Strandjord, R. E. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01056.x · Cited by 16
Reciprocal activation of leukocyte–endothelial adhesion molecules in acute coronary syndromes
Murphy, R. T., Foley, J. B., Crean, P., & Walsh, M. J. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00557-0 · Cited by 16
Kohara, K., Tabara, Y., Yamamoto, Y., Igase, M., & Miki, T. (2002) · Stroke · doi:10.1161/01.str.0000018974.05768.fb · Cited by 16
Ridker, P. M. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0080-8 · Cited by 16
“Together with basic laboratory data, these clinical studies and those focusing on interleukin-6 [19,21,22], cellular adhesion molecules [23, 24 ], and tumor necrosis factor [25] underscore the importance of inflammation in the atherogenic process.”
Method
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review